Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US2016159805A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016159805-A1 |
| Application number | US-201414904710-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 14, 2014 |
| Priority date | Jul 17, 2013 |
| Publication date | Jun 9, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are compounds of formula (I) which possess nematicidal properties wherein the residues have the meaning as indicated in the description.
Opening claim text (preview).
1 . Compound of formula (I) wherein Z is O or S, A 1 , A 2 , A 3 and A 4 are independently N or C—R 1 ; each W is independently hydrogen, halogen, cyano, nitro, SF 5 , OCN, SCN, Si(R 14 ) 3 , OR 4 , NR 5 R 6 , C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 ; OC(O)R 7 , OC(O)OR 8 , OC(O)NR 11 R 12 , OS(O) 2 R 9 , OS(O) 2 NR 11 R 12 , N(R 10 )C(O)R 7 , N(R 10 )C(O)NR 11 R 12 , N(R 10 )S(O) 2 R 9 , N(R 10 )S(O) 2 NR 11 R 12 , C 3 -C 7 -cycloalkyl, C 4 -C 8 -cycloalkylalkyl, C 6 -C 14 -cycloalkylcycloalkyl or C 5 -C 7 -cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, OR 4a and S(O) m R 9a ; or C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl or C 2 -C 6 -alkynyl, each substituted with 1 to 4 substituents independently selected from the group consisting of NR 5 R 6 , C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; or phenyl, naphthalenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C 2 -C 6 -alkoxyalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7a and N(R 10 )C(O)R 7a ; each R 1 is independently H, halogen, cyano, nitro, SF 5 , OCN, SCN, Si(R 14 ) 3 , OR 4 , NR 5 R 6 , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7 , OC(O)OR 8 , OC(O)NR 11 R 12 , OS(O) 2 R 9 , OS(O) 2 NR 11 R 12 , N(R 10 )C(O)R 7 , N(R 10 )C(O)NR 11 R 12 , N(R 10 )S(O) 2 R 9 or N(R 10 )S(O) 2 NR 11 R 12 ; or C 3 -C 7 -cycloalkyl, C 4 -C 8 -cycloalkylalkyl, C 6 -C 14 -cycloalkylcycloalkyl or C 5 -C 7 -cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, OR 4a and S(O) m R 9a ; or C 1 -C 6 -alkyl substituted with 1 to 4 substituents independently selected from the group consisting of cyano, nitro, OR 4 , NR 5 R 6 , C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; or phenyl, naphthalenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; R 2 is H, halogen, cyano, nitro, SF 5 , OCN, SCN, Si(R 14 ) 3 , OR 4 , NR 5 R 6 , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C 3 -C 7 -cycloalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7 , OC(O)OR 8 , OC(O)NR 11 R 12 , OS(O) 2 R 9 , OS(O) 2 NR 11 R 12 , N(R 10 )C(O)R 7 ,) N(R 10 )C(O)NR 11 R 12 , N(R 10 )S(O) 2 R 9 or N(R 10 )S(O) 2 NR 11 R 12 ; or C 3 -C 7 -cycloalkyl, C 4 -C 8 -cycloalkylalkyl, C 6 -C 14 -cycloalkylcycloalkyl or C 5 -C 7 -cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, OR 4a and S(O) m R 9a ; or C 1 -C 6 -alkyl substituted with 1 to 4 substituents independently selected from the group consisting of cyano, nitro, OR 4 , NR 5 R 6 , C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; or phenyl, naphthalenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; R 3 is H, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 or S(O) 2 NR 11 R 12 ; or C 3 -C 7 -cycloalkyl, C 4 -C 8 -cycloalkylalkyl or C 5 -C 7 -cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4a , and S(O) m R 9a ; or C 1 -C 6 -alkyl substituted with 1 to 4 substituents independently selected from the group consisting of cyano, nitro, OR 4 , NR 5 R 6 , C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; or C 1 -C 6 -alkyl substituted with 1 to 2 substituents independently selected from the group consisting of phenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C 2 -C 6 -alkoxyalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7a and N(R 10 )C(O)R 7a ; or phenyl optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C 2 -C 6 -alkoxyalkyl, C(X)R 1 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7a and N(R 10 )C(O)R 7a ; each R 4 is independently H, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl or C 2 -C 6 -haloalkynyl; or C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl or C 2 -C 6 -alkynyl, each substituted with 1 to 4 substituents independently selected from the group consisting of, cyano, nitro, OR 4a , NR 5a R 6a , C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , S(O) m R 9a and S(O) 2 NR 11 R 12 ; or C 3 -C 7 -cycloalkyl, C 4 -C 8 -cycloalkylalkyl, C 6 -C 14 -cycloalkylcycloalkyl or C 5 -C 7 -cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , OR 4a , C 2 -C 6 -alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11 R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ; each R 4a is independently H, C 1 -C 6 -alkyl or C 1 -C 6 -haloalkyl; each R 5 is independently H, NR 5a R 6a , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 or S(O) 2 NR 11 R 12 ; or C 3 -C 7 -cycloalkyl, C 4 -C 8 -cycloalkylalkyl, C 6 -C 14 -cycloalkylcycloalkyl or C 5 -C 7 -cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 -alkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -haloalkenyl, C(X)R 7a , C(O)OR 8 a, C(O)NR 11 R 12 , OR 4a , C 2 -C 6 -alkoxyalkyl, S(O)
having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system · CPC title
Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis · CPC title
Antiparasitic agents · CPC title
Ortho-condensed systems · CPC title
Anthelmintics · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.